Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Belinda Stock"'
Autor:
Belinda Stock, Milica Bunos, Eva Wingenfeld, Halvard Bonig, Christiane Hümmer, Ariane Krämer, Nadine Sorg, Erhard Seifried, Carolin Poppe
Publikováno v:
Transfusion. 55:1275-1282
BACKGROUND Red blood cell (RBC) depletion is a standard technique for preparation of ABO-incompatible bone marrow transplants (BMTs). Density centrifugation or apheresis are used successfully at clinical scale. The advent of a bone marrow (BM) proces
Autor:
Belinda Stock, Halvard Bonig, Christiane Hümmer, Volker Huppert, Eva Wingenfeld, Mike Essl, Kristina Reck, Juliane Stuth, Erhard Seifried, Milica Bunos, Carolin Poppe
Publikováno v:
Journal of Translational Medicine
Background Automation of cell therapy manufacturing promises higher productivity of cell factories, more economical use of highly-trained (and costly) manufacturing staff, facilitation of processes requiring manufacturing steps at inconvenient hours,
Autor:
Nadine, Sorg, Carolin, Poppe, Milica, Bunos, Eva, Wingenfeld, Christiane, Hümmer, Ariane, Krämer, Belinda, Stock, Erhard, Seifried, Halvard, Bonig
Publikováno v:
Transfusion. 55(6)
Red blood cell (RBC) depletion is a standard technique for preparation of ABO-incompatible bone marrow transplants (BMTs). Density centrifugation or apheresis are used successfully at clinical scale. The advent of a bone marrow (BM) processing module
Autor:
Klaus Dembowsky, Halvard Bonig, Christophe Escot, Eliza Wiercinska, Susanne Brauninger, Ariane Kraemer, Darja Karpova, Leon Hooftman, Garry Douglas, Belinda Stock, Eric Chevalier, Jochen Graff, Barbara Romagnoli
Publikováno v:
Blood. 126:511-511
Background: Stem cell mobilization (SCM) with G-CSF is efficient but - although overall safe - inconvenient because of the five-day injection regime and certain contraindications. Side effects, sometimes severe, are frequent. These disadvantages fuel
Autor:
Leon Hooftman, Halvard Bonig, Klaus Dembowski, Christopher Escot, Darja Karpova, Hans Martin, Belinda Stock, Jochen Graff, Barbara Romagnoli, Garry Douglas, Achim Wach, Eric Chevalier, Susanne Brauninger, Ariane Krämer, Eliza Wiercinska
Publikováno v:
Journal of Translational Medicine
Background Certain disadvantages of the standard hematopoietic stem and progenitor cell (HSPC) mobilizing agent G-CSF fuel the quest for alternatives. We herein report results of a Phase I dose escalation trial comparing mobilization with a peptidic